Literature DB >> 19169901

Pathophysiology of itching and sneezing in allergic rhinitis.

Oliver Pfaar1, U Raap, M Holz, K Hörmann, L Klimek.   

Abstract

Itching and sneezing represent two of the main bothersome symptoms, apart from nasal obstruction and rhinorrhea in allergic rhinitis. Apparently, activation of the central and peripheral nervous system plays a major role in the pathophysiology of this process. Sensory nerves of the afferent trigeminal system including myelinated Adelta-fibres and thin, non-myelinated C-fibres of the nasal mucosa transmit signals generating sensations, including itching and motor reflexes, such as sneezing. These nerves can be stimulated by products of allergic reactions and by external physical and chemical irritants. Via axon reflex inflammatory neuropeptides including the tachykinins substance P (SP) and neurokinin A (NKA) and the calcitonin gene related peptide are released, leading to vasodilatation, increased vascular permeability (concept of "neurogenic inflammation"), glandular activation, leukocyte recruitment and differentiation of immune cells including mast cells, eosinophils, lymphocytes and macrophages. The present paper describes nasal (micro-) anatomy and innervation and explains the central and peripheral mechanisms initiating itching and sneezing in allergic rhinitis. Further, the role of neuropeptides and neurotrophins with regard to neuronal and immune cell activation which might play a key role in the future treatment of allergic rhinitis are discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19169901     DOI: smw-12468

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  10 in total

Review 1.  Subjective nasal fullness and objective congestion.

Authors:  James N Baraniuk
Journal:  Proc Am Thorac Soc       Date:  2011-03

2.  Diode laser treatment in therapy-resistant allergic rhinitis: impact on nasal obstruction and associated symptoms.

Authors:  Philipp P Caffier; Hans Scherer; Konrad Neumann; Sven Lück; Harald Enzmann; Andreas Haisch
Journal:  Lasers Med Sci       Date:  2010-07-10       Impact factor: 3.161

3.  Intestinal epithelial stem/progenitor cells are controlled by mucosal afferent nerves.

Authors:  Ove Lundgren; Mats Jodal; Madeleine Jansson; Anders T Ryberg; Lennart Svensson
Journal:  PLoS One       Date:  2011-02-09       Impact factor: 3.240

4.  Strontium chloride hexahydrate as a candidate molecule for long-term treatment of allergic rhinitis.

Authors:  Emine Elif Altuntas; Nergiz Hacer Turgut; Kasım Durmuş; Ömer Tamer Doǧan; Melih Akyol
Journal:  Indian J Med Res       Date:  2017-07       Impact factor: 2.375

5.  Chinese Herbal Medicine to Treat Allergic Rhinitis: Evidence From a Meta-Analysis.

Authors:  Yuan Zhang; Luo Zhang; Xu Zhang; Feng Lan
Journal:  Allergy Asthma Immunol Res       Date:  2018-01       Impact factor: 5.764

Review 6.  A TRiP Through the Roles of Transient Receptor Potential Cation Channels in Type 2 Upper Airway Inflammation.

Authors:  Wout Backaert; Brecht Steelant; Peter W Hellings; Karel Talavera; Laura Van Gerven
Journal:  Curr Allergy Asthma Rep       Date:  2021-03-18       Impact factor: 4.806

7.  The anti-inflammatory effects of acupuncture and their relevance to allergic rhinitis: a narrative review and proposed model.

Authors:  John L McDonald; Allan W Cripps; Peter K Smith; Caroline A Smith; Charlie C Xue; Brenda Golianu
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-14       Impact factor: 2.629

8.  Knockdown of neurokinin-1 receptor expression by small interfering RNA prevents the development of allergic rhinitis in rats.

Authors:  Hong Wang; Ruxin Zhang; Jing Wu; Hua Hu
Journal:  Inflamm Res       Date:  2013-08-11       Impact factor: 4.575

9.  Suppression of neuropeptide production by quercetin in allergic rhinitis model rats.

Authors:  Misako Kashiwabara; Kazuhito Asano; Tomomi Mizuyoshi; Hitome Kobayashi
Journal:  BMC Complement Altern Med       Date:  2016-05-20       Impact factor: 3.659

10.  Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety study.

Authors:  Orestes Santos-Morales; Alina Díaz-Machado; Daise Jiménez-Rodríguez; Yaisel Pomares-Iturralde; Tatiana Festary-Casanovas; Carlos A González-Delgado; Sonia Pérez-Rodríguez; Eulalia Alfonso-Muñoz; Carmen Viada-González; Patricia Piedra-Sierra; Idrian García-García; Daniel Amaro-González; Julio César García-Rodríguez; Iliana Sosa-Testé; Alicia Lagarto-Parra; Laura Barrero-Viera; Marlene David-Baldo; Maura Tamayo-Rodríguez; Ivonne Rivero-Vázquez; Gricel González-Gamiz; Alis Martín-Trujillo; Yasmila Rodríguez-Fernández; Ana Alfa Ledo-de la Luz; Maylén Álvarez-Delgado; Ivón Howland-Álvarez; Yolanda Cruz-Gómez
Journal:  BMC Neurol       Date:  2017-07-04       Impact factor: 2.474

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.